ALT 0 3 0 3 B-clinical_variable
and 4 7 4 7 O
AST 8 11 8 11 B-clinical_variable
less 12 16 12 16 O
than 17 21 17 21 O
or 22 24 22 24 O
equal 25 30 25 30 O
to 31 33 31 33 O
5 34 35 34 35 B-upper_bound
times 36 41 36 41 I-upper_bound
ULN 42 45 42 45 I-upper_bound
for 46 49 46 49 O
patients 50 58 50 58 O
receiving 59 68 59 68 O
MAC 69 72 69 72 B-clinical_variable
or 73 75 73 75 O
ALT 76 79 76 79 O
and 80 83 80 83 O
AST 84 87 84 87 O
less 88 92 88 92 O
than 93 97 93 97 O
or 98 100 98 100 O
equal 101 106 101 106 O
to 107 109 107 109 O
10 110 112 110 112 B-upper_bound
times 113 118 113 118 I-upper_bound
ULN 119 122 119 122 I-upper_bound
for 123 126 123 126 O
patients 127 135 127 135 O
receiving 136 145 136 145 O
RIC 146 149 146 149 B-treatment
, 149 150 149 150 O
RIC 151 154 151 154 B-treatment
- 154 155 154 155 I-treatment
MMFor 155 160 155 160 I-treatment
IOC 161 164 161 164 I-treatment

Active 0 6 165 171 O
central 7 14 172 179 B-cancer
nervous 15 22 180 187 I-cancer
system 23 29 188 194 I-cancer
( 30 31 195 196 I-cancer
CNS 31 34 196 199 I-cancer
) 34 35 199 200 I-cancer
involvement 36 47 201 212 I-cancer
by 48 50 213 215 I-cancer
malignancy 51 61 216 226 I-cancer
, 61 62 226 227 O
except 63 69 228 234 O
in 70 72 235 237 O
cases 73 78 238 243 O
of 79 81 244 246 O
virus 82 87 247 252 O
- 87 88 252 253 O
associated 88 98 253 263 O
malignancies 99 111 264 276 B-cancer
with 112 116 277 281 O
CNS 117 120 282 285 O
involvement 121 132 286 297 O
in 133 135 298 300 O
which 136 141 301 306 O
case 142 146 307 311 O
the 147 150 312 315 O
patient 151 158 316 323 O
may 159 162 324 327 O
benefit 163 170 328 335 O
from 171 175 336 340 O
the 176 179 341 344 O
transplant 180 190 345 355 B-treatment
to 191 193 356 358 O
control 194 201 359 366 O
the 202 205 367 370 O
malignancy 206 216 371 381 O

Active 0 6 382 388 O
psychiatric 7 18 389 400 B-chronic_disease
disorder 19 27 401 409 I-chronic_disease
which 28 33 410 415 O
may 34 37 416 419 O
compromise 38 48 420 430 O
compliance 49 59 431 441 O
with 60 64 442 446 O
the 65 68 447 450 O
transplant 69 79 451 461 O
protocol 80 88 462 470 O
, 88 89 470 471 O
or 90 92 472 474 O
which 93 98 475 480 O
does 99 103 481 485 O
not 104 107 486 489 O
allow 108 113 490 495 O
for 114 117 496 499 O
appropriate 118 129 500 511 O
informed 130 138 512 520 O
consent 139 146 521 528 O

Age 0 3 529 532 B-age
greater 4 11 533 540 O
than 12 16 541 545 O
or 17 19 546 548 O
equal 20 25 549 554 O
to 26 28 555 557 O
4 29 30 558 559 B-lower_bound
and 31 34 560 563 O
weight 35 41 564 570 B-clinical_variable
of 42 44 571 573 O
greater 45 52 574 581 O
than 53 57 582 586 O
or 58 60 587 589 O
equal 61 66 590 595 O
to 67 69 596 598 O
15 70 72 599 601 B-lower_bound
kg 73 75 602 604 I-lower_bound

All 0 3 605 608 O
mutation 4 12 609 617 O
testing 13 20 618 625 O
will 21 25 626 630 O
be 26 28 631 633 O
performed 29 38 634 643 O
on 39 41 644 646 O
NIAID 42 47 647 652 O
protocols 48 57 653 662 O
( 58 59 663 664 O
such 59 63 664 668 O
as 64 66 669 671 O
07 67 69 672 674 O
- 69 70 674 675 O
I-0033 70 76 675 681 O
-Detection 77 87 682 692 O
and 88 91 693 696 O
Characterization 92 108 697 713 O
of 109 111 714 716 O
Infections 112 122 717 727 B-chronic_disease
and 123 126 728 731 O
Infection 127 136 732 741 O
Susceptibility 137 151 742 756 O
; 151 152 756 757 O
PI 153 155 758 760 O
: 155 156 760 761 O
Steve 157 162 762 767 O
Holland 163 170 768 775 O
) 170 171 775 776 O
, 171 172 776 777 O
with 173 177 778 782 O
genetic 178 185 783 790 O
counseling 186 196 791 801 O
and 197 200 802 805 O
education 201 210 806 815 O
through 211 218 816 823 O
these 219 224 824 829 O
established 225 236 830 841 O
protocols 237 246 842 851 O

As 0 2 852 854 O
therapeutic 3 14 855 866 O
agents 15 21 867 873 O
used 22 26 874 878 O
in 27 29 879 881 O
this 30 34 882 886 O
trial 35 40 887 892 O
may 41 44 893 896 O
be 45 47 897 899 O
harmful 48 55 900 907 O
to 56 58 908 910 O
a 59 60 911 912 O
fetus 61 66 913 918 O
, 66 67 918 919 O
women 68 73 920 925 B-gender
of 74 76 926 928 O
childbearing 77 89 929 941 O
potential 90 99 942 951 O
and 100 103 952 955 O
men 104 107 956 959 O
must 108 112 960 964 O
agree 113 118 965 970 B-contraception_consent
to 119 121 971 973 I-contraception_consent
use 122 125 974 977 I-contraception_consent
adequate 126 134 978 986 I-contraception_consent
contraception 135 148 987 1000 I-contraception_consent
( 149 150 1001 1002 O
hormonal 150 158 1002 1010 B-contraception_consent
or 159 161 1011 1013 O
barrier 162 169 1014 1021 B-contraception_consent
method 170 176 1022 1028 I-contraception_consent
of 177 179 1029 1031 I-contraception_consent
birth 180 185 1032 1037 I-contraception_consent
control 186 193 1038 1045 I-contraception_consent
; 193 194 1045 1046 O
abstinence 195 205 1047 1057 B-contraception_consent
) 205 206 1057 1058 O
prior 207 212 1059 1064 O
to 213 215 1065 1067 O
study 216 221 1068 1073 O
entry 222 227 1074 1079 O
and 228 231 1080 1083 O
for 232 235 1084 1087 O
at 236 238 1088 1090 O
least 239 244 1091 1096 O
one 245 248 1097 1100 B-lower_bound
year 249 253 1101 1105 O
post 254 258 1106 1110 O
- 258 259 1110 1111 O
allo 259 263 1111 1115 O
BMT 264 267 1116 1119 O
. 267 268 1119 1120 O
Should 269 275 1121 1127 O
a 276 277 1128 1129 O
woman 278 283 1130 1135 B-gender
become 284 290 1136 1142 B-pregnancy
pregnant 291 299 1143 1151 I-pregnancy
or 300 302 1152 1154 O
suspect 303 310 1155 1162 O
she 311 314 1163 1166 O
is 315 317 1167 1169 O
pregnant 318 326 1170 1178 O
while 327 332 1179 1184 O
she 333 336 1185 1188 O
or 337 339 1189 1191 O
her 340 343 1192 1195 O
partner 344 351 1196 1203 O
is 352 354 1204 1206 O
participating 355 368 1207 1220 O
in 369 371 1221 1223 O
the 372 375 1224 1227 O
study 376 381 1228 1233 O
, 381 382 1233 1234 O
she 383 386 1235 1238 O
should 387 393 1239 1245 O
inform 394 400 1246 1252 O
her 401 404 1253 1256 O
treating 405 413 1257 1265 O
physician 414 423 1266 1275 O
immediately 424 435 1276 1287 O

Availability 0 12 1288 1300 O
of 13 15 1301 1303 O
at 16 18 1304 1306 O
least 19 24 1307 1312 O
one 25 28 1313 1316 B-lower_bound
9 29 30 1317 1318 O
- 30 31 1318 1319 O
10/10 31 36 1319 1324 O
HLA 37 40 1325 1328 O
- 40 41 1328 1329 O
matched 41 48 1329 1336 O
related 49 56 1337 1344 O
( 57 58 1345 1346 O
excluding 58 67 1346 1355 O
an 68 70 1356 1358 O
identical 71 80 1359 1368 O
twin 81 85 1369 1373 O
) 85 86 1373 1374 O
or 87 89 1375 1377 O
unrelated 90 99 1378 1387 O
donor 100 105 1388 1393 O
, 105 106 1393 1394 O
or 107 109 1395 1397 O
an 110 112 1398 1400 O
HLA 113 116 1401 1404 O
- 116 117 1404 1405 O
haploidentical 117 131 1405 1419 O
related 132 139 1420 1427 O
donor 140 145 1428 1433 O

Bilirubin 0 9 1434 1443 B-clinical_variable
less 10 14 1444 1448 O
than 15 19 1449 1453 O
or 20 22 1454 1456 O
equal 23 28 1457 1462 O
to 29 31 1463 1465 O
3.0 32 35 1466 1469 B-upper_bound
mg 36 38 1470 1472 I-upper_bound
/ 38 39 1472 1473 I-upper_bound
dL 39 41 1473 1475 I-upper_bound
( 42 43 1476 1477 O
unless 43 49 1477 1483 O
due 50 53 1484 1487 O
to 54 56 1488 1490 O
Gilbert 57 64 1491 1498 B-chronic_disease
s 65 66 1499 1500 I-chronic_disease
syndrome 67 75 1501 1509 I-chronic_disease
or 76 78 1510 1512 O
hemolysis 79 88 1513 1522 B-chronic_disease
) 88 89 1522 1523 O
for 90 93 1524 1527 O
patients 94 102 1528 1536 O
receiving 103 112 1537 1546 O
MAC 113 116 1547 1550 B-treatment
, 116 117 1550 1551 O
RIC 118 121 1552 1555 B-treatment
or 122 124 1556 1558 O
RIC 125 128 1559 1562 B-treatment
- 128 129 1562 1563 I-treatment
MMF 129 132 1563 1566 I-treatment
and 133 136 1567 1570 O
bilirubin 137 146 1571 1580 B-clinical_variable
less 147 151 1581 1585 O
than 152 156 1586 1590 O
or 157 159 1591 1593 O
equal 160 165 1594 1599 O
to 166 168 1600 1602 O
5.0 169 172 1603 1606 B-upper_bound
mg 173 175 1607 1609 I-upper_bound
/ 175 176 1609 1610 I-upper_bound
dL 176 178 1610 1612 I-upper_bound
for 179 182 1613 1616 O
patients 183 191 1617 1625 O
receiving 192 201 1626 1635 O
IOC 202 205 1636 1639 B-treatment
( 206 207 1640 1641 O
unless 207 213 1641 1647 O
due 214 217 1648 1651 O
to 218 220 1652 1654 O
Gilbert 221 228 1655 1662 O
s 229 230 1663 1664 O
syndrome 231 239 1665 1673 O
or 240 242 1674 1676 O
hemolysis 243 252 1677 1686 O
) 252 253 1686 1687 O

Chronic 0 7 1688 1695 O
elevation 8 17 1696 1705 O
in 18 20 1706 1708 O
the 21 24 1709 1712 O
blood 25 30 1713 1718 O
( 31 32 1719 1720 O
greater 32 39 1720 1727 O
than 40 44 1728 1732 O
or 45 47 1733 1735 O
equal 48 53 1736 1741 O
to 54 56 1742 1744 O
2 57 58 1745 1746 B-lower_bound
documented 59 69 1747 1757 O
elevations 70 80 1758 1768 O
over 81 85 1769 1773 O
a 86 87 1774 1775 O
period 88 94 1776 1782 O
of 95 97 1783 1785 O
6 98 99 1786 1787 O
months 100 106 1788 1794 O
or 107 109 1795 1797 O
longer 110 116 1798 1804 O
) 116 117 1804 1805 O
of 118 120 1806 1808 O
a 121 122 1809 1810 O
latent 123 129 1811 1817 B-chronic_disease
virus 130 135 1818 1823 I-chronic_disease
( 136 137 1824 1825 O
EBV 137 140 1825 1828 B-chronic_disease
, 140 141 1828 1829 O
CMV 142 145 1830 1833 B-chronic_disease
, 145 146 1833 1834 O
HHV6 147 151 1835 1839 B-chronic_disease
, 151 152 1839 1840 O
HHV8 153 157 1841 1845 B-chronic_disease
, 157 158 1845 1846 O
etc 159 162 1847 1850 O
. 162 163 1850 1851 O
) 163 164 1851 1852 O

Donors 0 6 1853 1859 O
must 7 11 1860 1864 B-pregnancy
not 12 15 1865 1868 I-pregnancy
be 16 18 1869 1871 I-pregnancy
pregnant 19 27 1872 1880 I-pregnancy

Donors 0 6 1881 1887 O
of 7 9 1888 1890 O
childbearing 10 22 1891 1903 O
potential 23 32 1904 1913 O
must 33 37 1914 1918 O
use 38 41 1919 1922 B-contraception_consent
an 42 44 1923 1925 I-contraception_consent
effective 45 54 1926 1935 I-contraception_consent
method 55 61 1936 1942 I-contraception_consent
of 62 64 1943 1945 I-contraception_consent
contraception 65 78 1946 1959 I-contraception_consent
, 78 79 1959 1960 O
including 80 89 1961 1970 O
one 90 93 1971 1974 O
or 94 96 1975 1977 O
more 97 101 1978 1982 O
of 102 104 1983 1985 O
the 105 108 1986 1989 O
following 109 118 1990 1999 O
: 118 119 1999 2000 O
intrauterine 120 132 2001 2013 B-contraception_consent
device 133 139 2014 2020 I-contraception_consent
, 139 140 2020 2021 O
hormonal 141 149 2022 2030 B-contraception_consent
( 150 151 2031 2032 O
birth 151 156 2032 2037 B-contraception_consent
control 157 164 2038 2045 I-contraception_consent
pills 165 170 2046 2051 I-contraception_consent
, 170 171 2051 2052 O
injections 172 182 2053 2063 B-contraception_consent
, 182 183 2063 2064 O
or 184 186 2065 2067 O
implants 187 195 2068 2076 B-contraception_consent
) 195 196 2076 2077 O
, 196 197 2077 2078 O
tubal 198 203 2079 2084 B-contraception_consent
ligation 204 212 2085 2093 I-contraception_consent
/ 212 213 2093 2094 O
hysterectomy 213 225 2094 2106 B-contraception_consent
, 225 226 2106 2107 O
partner 227 234 2108 2115 O
s 235 236 2116 2117 O
vasectomy 237 246 2118 2127 B-contraception_consent
, 246 247 2127 2128 O
barrier 248 255 2129 2136 B-contraception_consent
methods 256 263 2137 2144 I-contraception_consent
( 264 265 2145 2146 O
condom 265 271 2146 2152 B-contraception_consent
, 271 272 2152 2153 O
diaphragm 273 282 2154 2163 B-contraception_consent
, 282 283 2163 2164 O
or 284 286 2165 2167 O
cervical 287 295 2168 2176 B-contraception_consent
cap 296 299 2177 2180 I-contraception_consent
) 299 300 2180 2181 O
, 300 301 2181 2182 O
or 302 304 2183 2185 O
abstinence 305 315 2186 2196 B-contraception_consent
from 316 320 2197 2201 O
the 321 324 2202 2205 O
day 325 328 2206 2209 O
of 329 331 2210 2212 O
signing 332 339 2213 2220 O
consent 340 347 2221 2228 O
through 348 355 2229 2236 O
day 356 359 2237 2240 O
+60 360 363 2241 2244 O
of 364 366 2245 2247 O
the 367 370 2248 2251 O
recipient 371 380 2252 2261 O
s 381 382 2262 2263 O
allo 383 387 2264 2268 O
- 387 388 2268 2269 O
BMT 388 391 2269 2272 O

Estimated 0 9 2273 2282 B-clinical_variable
creatinine 10 20 2283 2293 I-clinical_variable
clearance 21 30 2294 2303 I-clinical_variable
of 31 33 2304 2306 O
greater 34 41 2307 2314 O
than 42 46 2315 2319 O
or 47 49 2320 2322 O
equal 50 55 2323 2328 O
to 56 58 2329 2331 O
40 59 61 2332 2334 B-lower_bound
mL 62 64 2335 2337 I-lower_bound
/ 64 65 2337 2338 I-lower_bound
min/1.73 65 73 2338 2346 I-lower_bound
m(2 74 77 2347 2350 I-lower_bound
) 77 78 2350 2351 I-lower_bound
, 78 79 2351 2352 O
calculated 80 90 2353 2363 O
using 91 96 2364 2369 O
the 97 100 2370 2373 O
Cockcroft 101 110 2374 2383 O
- 110 111 2383 2384 O
Gault 111 116 2384 2389 O
equation 117 125 2390 2398 O
for 126 129 2399 2402 O
adults 130 136 2403 2409 O
and 137 140 2410 2413 O
Schwartz 141 149 2414 2422 O
formula 150 157 2423 2430 O
for 158 161 2431 2434 O
pediatric 162 171 2435 2444 O
patients 172 180 2445 2453 O
, 180 181 2453 2454 O
for 182 185 2455 2458 O
patients 186 194 2459 2467 O
with 195 199 2468 2472 O
creatinine 200 210 2473 2483 B-clinical_variable
levels 211 217 2484 2490 I-clinical_variable
above 218 223 2491 2496 O
the 224 227 2497 2500 O
institutional 228 241 2501 2514 O
upper 242 247 2515 2520 O
limit 248 253 2521 2526 O
of 254 256 2527 2529 O
normal 257 263 2530 2536 O

Evidence 0 8 2537 2545 O
of 9 11 2546 2548 O
immune 12 18 2549 2555 O
dysregulation 19 32 2556 2569 O
, 32 33 2569 2570 O
as 34 36 2571 2573 O
manifested 37 47 2574 2584 O
by 48 50 2585 2587 O
autoimmune 51 61 2588 2598 B-chronic_disease
disease 62 69 2599 2606 I-chronic_disease
, 69 70 2606 2607 O
atopy 71 76 2608 2613 B-chronic_disease
, 76 77 2613 2614 O
hemophagocytic 78 92 2615 2629 B-chronic_disease
lymphohistiocytosis 93 112 2630 2649 I-chronic_disease
/ 112 113 2649 2650 O
macrophage 113 123 2650 2660 B-chronic_disease
activation 124 134 2661 2671 I-chronic_disease
syndrome 135 143 2672 2680 I-chronic_disease
, 143 144 2680 2681 O
granulomas 145 155 2682 2692 B-chronic_disease
, 155 156 2692 2693 O
splenomegaly 157 169 2694 2706 B-chronic_disease
, 169 170 2706 2707 O
or 171 173 2708 2710 O
lymphadenopathy 174 189 2711 2726 B-chronic_disease

HIV 0 3 2727 2730 B-chronic_disease
negative 4 12 2731 2739 O
, 12 13 2739 2740 O
hepatitis 14 23 2741 2750 B-chronic_disease
B 24 25 2751 2752 I-chronic_disease
virus 26 31 2753 2758 O
surface 32 39 2759 2766 O
antigen 40 47 2767 2774 O
negative 48 56 2775 2783 O
, 56 57 2783 2784 O
and 58 61 2785 2788 O
hepatitis 62 71 2789 2798 B-chronic_disease
C 72 73 2799 2800 I-chronic_disease
virus 74 79 2801 2806 O
antibody 80 88 2807 2815 O
negative 89 97 2816 2824 O

Hematologic 0 11 2825 2836 B-cancer
malignancy 12 22 2837 2847 I-cancer
or 23 25 2848 2850 O
lymphoproliferative 26 45 2851 2870 B-cancer
disorder 46 54 2871 2879 I-cancer

History 0 7 2880 2887 O
of 8 10 2888 2890 O
a 11 12 2891 2892 O
psychiatric 13 24 2893 2904 B-chronic_disease
disorder 25 33 2905 2913 I-chronic_disease
which 34 39 2914 2919 O
in 40 42 2920 2922 O
the 43 46 2923 2926 O
opinion 47 54 2927 2934 O
of 55 57 2935 2937 O
the 58 61 2938 2941 O
PI 62 64 2942 2944 O
may 65 68 2945 2948 O
compromise 69 79 2949 2959 O
compliance 80 90 2960 2970 O
with 91 95 2971 2975 O
the 96 99 2976 2979 O
transplant 100 110 2980 2990 O
protocol 111 119 2991 2999 O
, 119 120 2999 3000 O
or 121 123 3001 3003 O
which 124 129 3004 3009 O
does 130 134 3010 3014 O
not 135 138 3015 3018 O
allow 139 144 3019 3024 O
for 145 148 3025 3028 O
appropriate 149 160 3029 3040 O
informed 161 169 3041 3049 O
consent 170 177 3050 3057 O

History 0 7 3058 3065 O
of 8 10 3066 3068 O
allergic 11 19 3069 3077 O
reactions 20 29 3078 3087 O
attributed 30 40 3088 3098 O
to 41 43 3099 3101 O
compounds 44 53 3102 3111 O
of 54 56 3112 3114 O
similar 57 64 3115 3122 O
chemical 65 73 3123 3131 O
or 74 76 3132 3134 O
biologic 77 85 3135 3143 O
composition 86 97 3144 3155 O
to 98 100 3156 3158 O
agents 101 107 3159 3165 O
( 108 109 3166 3167 O
cyclophosphamide 109 125 3167 3183 B-allergy_name
, 125 126 3183 3184 O
busulfan 127 135 3185 3193 B-allergy_name
, 135 136 3193 3194 O
pentostatin 137 148 3195 3206 B-allergy_name
, 148 149 3206 3207 O
sirolimus 150 159 3208 3217 B-allergy_name
, 159 160 3217 3218 O
MMF 161 164 3219 3222 B-allergy_name
, 164 165 3222 3223 O
G 166 167 3224 3225 B-allergy_name
- 167 168 3225 3226 I-allergy_name
CSF 168 171 3226 3229 I-allergy_name
) 171 172 3229 3230 O
used 173 177 3231 3235 O
in 178 180 3236 3238 O
the 181 184 3239 3242 O
study 185 190 3243 3248 O

Hypogammaglobulinemia 0 21 3249 3270 B-chronic_disease
, 21 22 3270 3271 O
dysglobulinemia 23 38 3272 3287 B-chronic_disease
, 38 39 3287 3288 O
or 40 42 3289 3291 O
impaired 43 51 3292 3300 B-chronic_disease
response 52 60 3301 3309 I-chronic_disease
to 61 63 3310 3312 I-chronic_disease
vaccination 64 75 3313 3324 I-chronic_disease

Infection 0 9 3325 3334 O
with 10 14 3335 3339 O
an 15 17 3340 3342 O
opportunistic 18 31 3343 3356 B-chronic_disease
organism 32 40 3357 3365 I-chronic_disease

Karnofsky 0 9 3366 3375 B-clinical_variable
or 10 12 3376 3378 O
Lansky 13 19 3379 3385 B-clinical_variable
performance 20 31 3386 3397 I-clinical_variable
status 32 38 3398 3404 I-clinical_variable
of 39 41 3405 3407 O
greater 42 49 3408 3415 O
than 50 54 3416 3420 O
or 55 57 3421 3423 O
equal 58 63 3424 3429 O
to 64 66 3430 3432 O
60 67 69 3433 3435 B-lower_bound
% 69 70 3435 3436 I-lower_bound
or 71 73 3437 3439 O
ECOG 74 78 3440 3444 B-clinical_variable
performance 79 90 3445 3456 I-clinical_variable
status 91 97 3457 3463 I-clinical_variable
of 98 100 3464 3466 O
2 101 102 3467 3468 B-upper_bound
or 103 105 3469 3471 O
less 106 110 3472 3476 O

Karnofsky 0 9 3477 3486 B-clinical_variable
performance 10 21 3487 3498 I-clinical_variable
status 22 28 3499 3505 I-clinical_variable
of 29 31 3506 3508 O
90 32 34 3509 3511 B-lower_bound
- 34 35 3511 3512 O
100 35 38 3512 3515 B-upper_bound
% 38 39 3515 3516 I-upper_bound
( 40 41 3517 3518 O
adults 41 47 3518 3524 O
) 47 48 3524 3525 O
or 49 51 3526 3528 O
Lansky 52 58 3529 3535 B-clinical_variable
Play 59 63 3536 3540 I-clinical_variable
Performance 64 75 3541 3552 I-clinical_variable
Status 76 82 3553 3559 I-clinical_variable
of 83 85 3560 3562 O
100 86 89 3563 3566 O
% 89 90 3566 3567 O
( 91 92 3568 3569 O
children 92 100 3569 3577 O
) 100 101 3577 3578 O

Left 0 4 3579 3583 B-clinical_variable
ventricular 5 16 3584 3595 I-clinical_variable
ejection 17 25 3596 3604 I-clinical_variable
fraction 26 34 3605 3613 I-clinical_variable
( 35 36 3614 3615 I-clinical_variable
LVEF 36 40 3615 3619 I-clinical_variable
) 40 41 3619 3620 I-clinical_variable
greater 42 49 3621 3628 O
than 50 54 3629 3633 O
or 55 57 3634 3636 O
equal 58 63 3637 3642 O
to 64 66 3643 3645 O
40 67 69 3646 3648 B-lower_bound
% 69 70 3648 3649 I-lower_bound
by 71 73 3650 3652 O
2D 74 76 3653 3655 B-treatment
echocardiogram 77 91 3656 3670 I-treatment
( 92 93 3671 3672 I-treatment
ECHO 93 97 3672 3676 I-treatment
) 97 98 3676 3677 I-treatment
or 99 101 3678 3680 O
MUGA 102 106 3681 3685 B-treatment
, 106 107 3685 3686 O
or 108 110 3687 3689 O
left 111 115 3690 3694 B-clinical_variable
ventricular 116 127 3695 3706 I-clinical_variable
shortening 128 138 3707 3717 I-clinical_variable
fraction 139 147 3718 3726 I-clinical_variable
greater 148 155 3727 3734 O
than 156 160 3735 3739 O
or 161 163 3740 3742 O
equal 164 169 3743 3748 O
to 170 172 3749 3751 O
20 173 175 3752 3754 B-lower_bound
% 175 176 3754 3755 I-lower_bound
by 177 179 3756 3758 O
ECHO 180 184 3759 3763 O
for 185 188 3764 3767 O
patients 189 197 3768 3776 O
receiving 198 207 3777 3786 O
MAC 208 211 3787 3790 B-treatment
, 211 212 3790 3791 O
RIC 213 216 3792 3795 B-treatment
, 216 217 3795 3796 O
or 218 220 3797 3799 O
RIC 221 224 3800 3803 B-treatment
- 224 225 3803 3804 I-treatment
MMF 225 228 3804 3807 I-treatment
, 228 229 3807 3808 O
or 230 232 3809 3811 O
LVEF 233 237 3812 3816 O
greater 238 245 3817 3824 O
than 246 250 3825 3829 O
or 251 253 3830 3832 O
equal 254 259 3833 3838 O
to 260 262 3839 3841 O
30 263 265 3842 3844 B-lower_bound
% 265 266 3844 3845 I-lower_bound
if 267 269 3846 3848 O
the 270 273 3849 3852 O
patient 274 281 3853 3860 O
has 282 285 3861 3864 O
radiologic 286 296 3865 3875 O
evidence 297 305 3876 3884 O
of 306 308 3885 3887 O
aortic 309 315 3888 3894 O
, 315 316 3894 3895 O
renal 317 322 3896 3901 O
, 322 323 3901 3902 O
or 324 326 3903 3905 O
coronary 327 335 3906 3914 O
artery 336 342 3915 3921 O
vasculitis 343 353 3922 3932 O
. 353 354 3932 3933 O
LVEF 355 359 3934 3938 O
greater 360 367 3939 3946 O
than 368 372 3947 3951 O
or 373 375 3952 3954 O
equal 376 381 3955 3960 O
to 382 384 3961 3963 O
30 385 387 3964 3966 O
% 387 388 3966 3967 O
for 389 392 3968 3971 O
patients 393 401 3972 3980 O
receiving 402 411 3981 3990 O
IOC 412 415 3991 3994 B-treatment

Life 0 4 3995 3999 O
- 4 5 3999 4000 O
threatening 5 16 4000 4011 O
, 16 17 4011 4012 O
organ 18 23 4013 4018 O
- 23 24 4018 4019 O
threatening 24 35 4019 4030 O
, 35 36 4030 4031 O
or 37 39 4032 4034 O
severely 40 48 4035 4043 O
disfiguring 49 60 4044 4055 O
infection 61 70 4056 4065 B-chronic_disease

MagT1 0 5 4066 4071 O
mutation 6 14 4072 4080 O
and 15 18 4081 4084 O
active 19 25 4085 4091 O
need 26 30 4092 4096 O
to 31 33 4097 4099 O
take 34 38 4100 4104 O
anti 39 43 4105 4109 B-treatment
- 43 44 4109 4110 I-treatment
platelet 44 52 4110 4118 I-treatment
agents 53 59 4119 4125 I-treatment
and/or 60 66 4126 4132 O
therapeutic 67 78 4133 4144 B-treatment
anti 79 83 4145 4149 I-treatment
- 83 84 4149 4150 I-treatment
coagulation 84 95 4150 4161 I-treatment
that 96 100 4162 4166 O
can 101 104 4167 4170 O
not 104 107 4170 4173 O
be 108 110 4174 4176 O
interrupted 111 122 4177 4188 O
during 123 129 4189 4195 O
aplasia 130 137 4196 4203 B-chronic_disease

Not 0 3 4204 4207 B-pregnancy
pregnant 4 12 4208 4216 I-pregnancy
or 13 15 4217 4219 O
breastfeeding 16 29 4220 4233 O

PID 0 3 4234 4237 B-chronic_disease
as 4 6 4238 4240 O
defined 7 14 4241 4248 O
by 15 17 4249 4251 O
monogenetic 18 29 4252 4263 O
mutation 30 38 4264 4272 O
or 39 41 4273 4275 O
, 41 42 4275 4276 O
in 43 45 4277 4279 O
the 46 49 4280 4283 O
absence 50 57 4284 4291 O
of 58 60 4292 4294 O
a 61 62 4295 4296 O
PID 63 66 4297 4300 O
- 66 67 4300 4301 O
associated 67 77 4301 4311 O
genetic 78 85 4312 4319 O
mutation 86 94 4320 4328 O
, 94 95 4328 4329 O
patients 96 104 4330 4338 O
with 105 109 4339 4343 O
an 110 112 4344 4346 O
immune 113 119 4347 4353 O
defect 120 126 4354 4360 O
potentially 127 138 4361 4372 O
amenable 139 147 4373 4381 O
to 148 150 4382 4384 O
allo 151 155 4385 4389 O
BMT 156 159 4390 4393 B-treatment
who 160 163 4394 4397 O
meet 164 168 4398 4402 O
the 169 172 4403 4406 O
clinical 173 181 4407 4415 O
history 182 189 4416 4423 O
criteria 190 198 4424 4432 O
below 199 204 4433 4438 O
may 205 208 4439 4442 O
be 209 211 4443 4445 O
eligible 212 220 4446 4454 O
upon 221 225 4455 4459 O
discussion 226 236 4460 4470 O
with 237 241 4471 4475 O
the 242 245 4476 4479 O
PI 246 248 4480 4482 O

Patients 0 8 4483 4491 O
age 9 12 4492 4495 B-age
greater 13 20 4496 4503 O
than 21 25 4504 4508 O
or 26 28 4509 4511 O
equal 29 34 4512 4517 O
to 35 37 4518 4520 O
4 38 39 4521 4522 B-lower_bound
through 40 47 4523 4530 O
75 48 50 4531 4533 B-upper_bound
years 51 56 4534 4539 I-upper_bound

Patients 0 8 4540 4548 O
receiving 9 18 4549 4558 O
standard 19 27 4559 4567 B-treatment
therapy 28 35 4568 4575 I-treatment
will 36 40 4576 4580 O
be 41 43 4581 4583 O
told 44 48 4584 4588 O
about 49 54 4589 4594 O
the 55 58 4595 4598 O
therapy 59 66 4599 4606 O
, 66 67 4606 4607 O
associated 68 78 4608 4618 O
risks 79 84 4619 4624 O
, 84 85 4624 4625 O
potential 86 95 4626 4635 O
benefits 96 104 4636 4644 O
, 104 105 4644 4645 O
alternatives 106 118 4646 4658 O
to 119 121 4659 4661 O
the 122 125 4662 4665 O
proposed 126 134 4666 4674 B-treatment
therapy 135 142 4675 4682 I-treatment
, 142 143 4682 4683 O
and 144 147 4684 4687 O
the 148 151 4688 4691 O
availability 152 164 4692 4704 O
of 165 167 4705 4707 O
receiving 168 177 4708 4717 O
the 178 181 4718 4721 O
same 182 186 4722 4726 O
treatment 187 196 4727 4736 B-treatment
elsewhere 197 206 4737 4746 O
, 206 207 4746 4747 O
outside 208 215 4748 4755 O
of 216 218 4756 4758 O
a 219 220 4759 4760 O
research 221 229 4761 4769 O
protocol 230 238 4770 4778 O

Patients 0 8 4779 4787 O
who 9 12 4788 4791 O
are 13 16 4792 4795 O
receiving 17 26 4796 4805 O
any 27 30 4806 4809 O
other 31 36 4810 4815 O
investigational 37 52 4816 4831 B-treatment
agents 53 59 4832 4838 I-treatment
, 59 60 4838 4839 O
with 61 65 4840 4844 O
the 66 69 4845 4848 O
exception 70 79 4849 4858 O
of 80 82 4859 4861 O
virus 83 88 4862 4867 B-treatment
- 88 89 4867 4868 I-treatment
specific 89 97 4868 4876 I-treatment
cytotoxic 98 107 4877 4886 I-treatment
T 108 109 4887 4888 I-treatment
- 109 110 4888 4889 I-treatment
cells 110 115 4889 4894 I-treatment
for 116 119 4895 4898 O
the 120 123 4899 4902 O
treatment 124 133 4903 4912 B-treatment
of 134 136 4913 4915 O
viral 137 142 4916 4921 B-chronic_disease
infection 143 152 4922 4931 I-chronic_disease
/ 152 153 4931 4932 I-chronic_disease
reactivation 153 165 4932 4944 I-chronic_disease
prior 166 171 4945 4950 O
to 172 174 4951 4953 O
allo 175 179 4954 4958 O
BMT 180 183 4959 4962 B-treatment

Patients 0 8 4963 4971 O
with 9 13 4972 4976 O
hemophagocytic 14 28 4977 4991 B-chronic_disease
lymphohistiocytosis 29 48 4992 5011 I-chronic_disease
or 49 51 5012 5014 O
macrophage 52 62 5015 5025 B-chronic_disease
activation 63 73 5026 5036 I-chronic_disease
syndrome 74 82 5037 5045 I-chronic_disease
related 83 90 5046 5053 O
to 91 93 5054 5056 O
an 94 96 5057 5059 O
underlying 97 107 5060 5070 O
lymphoma 108 116 5071 5079 B-cancer
with 117 121 5080 5084 O
no 122 124 5085 5087 O
other 125 130 5088 5093 O
clinical 131 139 5094 5102 O
history 140 147 5103 5110 O
suggestive 148 158 5111 5121 O
of 159 161 5122 5124 O
a 162 163 5125 5126 O
primary 164 171 5127 5134 B-chronic_disease
immunodeficiency 172 188 5135 5151 I-chronic_disease

Protracted 0 10 5152 5162 O
or 11 13 5163 5165 O
recurrent 14 23 5166 5175 O
infections 24 34 5176 5186 B-chronic_disease
requiring 35 44 5187 5196 O
unusually 45 54 5197 5206 O
long 55 59 5207 5211 O
or 60 62 5212 5214 O
repeated 63 71 5215 5223 O
courses 72 79 5224 5231 O
of 80 82 5232 5234 O
antibiotics 83 94 5235 5246 B-treatment

Related 0 7 5247 5254 O
donors 8 14 5255 5261 O
will 15 19 5262 5266 O
undergo 20 27 5267 5274 O
the 28 31 5275 5278 O
Donor 32 37 5279 5284 O
Health 38 44 5285 5291 O
History 45 52 5292 5299 O
Screen 53 59 5300 5306 O
by 60 62 5307 5309 O
skilled 63 70 5310 5317 O
staff 71 76 5318 5323 O
in 77 79 5324 5326 O
the 80 83 5327 5330 O
Blood 84 89 5331 5336 O
Services 90 98 5337 5345 O
Section 99 106 5346 5353 O
for 107 110 5354 5357 O
adult 111 116 5358 5363 O
donors 117 123 5364 5370 O
and 124 127 5371 5374 O
age 128 131 5375 5378 B-age
- 131 132 5378 5379 O
appropriate 132 143 5379 5390 O
questioning 144 155 5391 5402 O
when 156 160 5403 5407 O
indicated 161 170 5408 5417 O
for 171 174 5418 5421 O
pediatric 175 184 5422 5431 O
donors 185 191 5432 5438 O
to 192 194 5439 5441 O
determine 195 204 5442 5451 O
donor 205 210 5452 5457 O
eligibility 211 222 5458 5469 O
using 223 228 5470 5475 O
standard 229 237 5476 5484 O
DTM 238 241 5485 5488 O
criteria 242 250 5489 5497 O

Related 0 7 5498 5505 O
donors 8 14 5506 5512 O
: 14 15 5512 5513 O
No 16 18 5514 5516 O
history 19 26 5517 5524 O
of 27 29 5525 5527 O
opportunistic 30 43 5528 5541 B-chronic_disease
infections 44 54 5542 5552 I-chronic_disease
, 54 55 5552 5553 O
autoimmunity 56 68 5554 5566 O
, 68 69 5566 5567 O
hemoglobinopathy 70 86 5568 5584 B-chronic_disease
, 86 87 5584 5585 O
red 88 91 5586 5589 B-chronic_disease
cell 92 96 5590 5594 I-chronic_disease
enzymopathy 97 108 5595 5606 I-chronic_disease
, 108 109 5606 5607 O
or 110 112 5608 5610 O
malignancy 113 123 5611 5621 B-cancer
, 123 124 5621 5622 O
apart 125 130 5623 5628 O
from 131 135 5629 5633 O
nonmelanomatous 136 151 5634 5649 B-cancer
skin 152 156 5650 5654 I-cancer
cancer 157 163 5655 5661 I-cancer
or 164 166 5662 5664 O
healed 167 173 5665 5671 O
cervical 174 182 5672 5680 B-cancer
cancer 183 189 5681 5687 I-cancer
in 190 192 5688 5690 I-cancer
situ 193 197 5691 5695 I-cancer

Virus 0 5 5696 5701 O
- 5 6 5701 5702 O
associated 6 16 5702 5712 O
solid 17 22 5713 5718 B-cancer
tumor 23 28 5719 5724 I-cancer
malignancy 29 39 5725 5735 B-cancer
or 40 42 5736 5738 O
pre 43 46 5739 5742 O
- 46 47 5742 5743 O
cancerous 47 56 5743 5752 O
lesion 57 63 5753 5759 O

